MEDICINOVA INC — Investor Relations & Filings
MediciNova Inc. is a biopharmaceutical company focused on developing novel small molecule therapeutics for serious diseases with unmet medical needs. Its pipeline targets neurology, respiratory, and liver diseases. Key product candidates include MN-166 (ibudilast), which is being developed for indications such as Amyotrophic Lateral Sclerosis (ALS), Progressive Multiple Sclerosis, Oncology/Glioblastoma, Chemotherapy-Induced Peripheral Neuropathy (CIPN), and Acute Respiratory Distress Syndrome (ARDS)/Lung Injury. MN-166 has also been marketed in Japan and Korea for post-stroke complications and bronchial asthma. Another candidate, MN-001 (tipelukast), is in development for Non-Alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes Mellitus, and Hypertriglyceridemia. The company's mission involves acquiring and accelerating the global development and commercialization of these therapeutics.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q | 2026-05-14 | English | |
| ARS | 2026-04-29 | English | |
| DEFA14A | 2026-04-29 | English | |
| DEF 14A | 2026-04-29 | English | |
| PRER14A | 2026-04-20 | English | |
| PRE 14A | 2026-04-17 | English |
Browse filings by year
3 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 46722291 | 10-Q | 2026-05-14 | English | ||
| 46722292 | ARS | 2026-04-29 | English | ||
| 46722293 | DEFA14A | 2026-04-29 | English | ||
| 46722295 | DEF 14A | 2026-04-29 | English | ||
| 46722297 | PRER14A | 2026-04-20 | English | ||
| 46722298 | PRE 14A | 2026-04-17 | English | ||
| 46722305 | 10-K | 2026-03-10 | English | ||
| 46722300 | 8-K | 2026-02-20 | English | ||
|
2025
7 filings
| |||||
| 46722307 | 424B5 | 2025-12-30 | English | ||
| 46722309 | 8-K | 2025-12-30 | English | ||
| 46722311 | Regulatory Filings 2025 | 2025-12-12 | English | ||
| 46722313 | S-3 | 2025-12-05 | English | ||
| 46722317 | 10-Q | 2025-11-12 | English | ||
| 46722318 | Regulatory Filings 2025 | 2025-10-01 | English | ||
| 46722321 | S-1 | 2025-08-22 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BriaCell Therapeutics Corp.
Developing targeted cellular immunotherapies using whole-ce…
|
BCTX | CA | Manufacturing |
|
BridgeBio Oncology Therapeutics, Inc.
Clinical-stage biopharma developing inhibitors for genetica…
|
BBOT | US | Manufacturing |
|
BridgeBio Pharma, Inc.
Develops transformative medicines for genetic diseases and …
|
BBIO | US | Manufacturing |
|
Brightgene Bio-Medical Technology Co., Ltd.
Research-driven developer of complex APIs, high-end generic…
|
688166 | CN | Manufacturing |
|
BRIGHT MINDS BIOSCIENCES INC.
Develops selective serotonin agonists for neurological and …
|
DRUG | US | Manufacturing |
|
BrightPath Biotherapeutics Co., Ltd.
A clinical-stage biopharma company developing cancer immuno…
|
4594 | JP | Manufacturing |
|
Brii Biosciences Limited
Developing first-in-class therapies targeting infectious an…
|
2137 | KY | Manufacturing |
|
BRISTOL MYERS SQUIBB CO
A global biopharmaceutical company that discovers, develops…
|
BMY | US | Manufacturing |
|
BROOKS LABORATORIES LIMITED
Pharmaceutical manufacturer specializing in CRAMS and diver…
|
BROOKS | IN | Manufacturing |
|
BUKWANG PHARMACEUTICAL IND CO.,LTD
An R&D-focused company developing drugs for CNS disorders a…
|
003000 | KR | Manufacturing |
MEDICINOVA INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/72582/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=72582 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=72582 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=72582 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 72582}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for MEDICINOVA INC (id: 72582)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.